Early-stage corneal toxicity secondary to high-dose systemic cytarabine: a case report

[1]  R. Hill,et al.  Lineage tracing in the adult mouse corneal epithelium supports the limbal epithelial stem cell hypothesis with intermittent periods of stem cell quiescence☆ , 2015, Stem cell research.

[2]  J. Becher,et al.  Cytosine-Arabinoside-Induced Keratopathy: A Model of Corneal Proliferation Kinetics , 2010, Ophthalmologica.

[3]  J. Salmon,et al.  Cytarabine-induced corneal toxicity , 2003, Eye.

[4]  H. Lazarus,et al.  Comparison of the prophylactic effects of 2-deoxycytidine and prednisolone for high-dose intravenous cytarabine-induced keratitis. , 1987, American journal of ophthalmology.

[5]  M. Fey.  High-dose cytosine arabinoside therapy for refractory leukemia. , 1984, Blood.

[6]  D. Heuer,et al.  Ocular toxicity from high‐dose cytosine arabinoside , 1983, Cancer.

[7]  H. Lazarus,et al.  Topical corticosteroid therapy for corneal toxicity from systemically administered cytarabine. , 1982, American journal of ophthalmology.

[8]  B. Johnson,et al.  Corneal toxicity with systemic cytarabine. , 1981, American journal of ophthalmology.

[9]  R. Momparler,et al.  A model for the chemotherapy of acute leukemia with 1-beta-D-arabinofuranosylcytosine. , 1974, Cancer research.

[10]  A. Schut,et al.  Studies with cytarabine HCl (CA) in normal eyes of man, monkey and rabbit. , 1965, American journal of ophthalmology.

[11]  J. E. Robbins,et al.  CORNEAL TOXICITY OF CYTOSINE ARABINOSIDE. , 1964, Archives of ophthalmology.

[12]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[13]  J. Stentoft.  The Toxicity of Cytarabine , 1990, Drug safety.